Evaluation of the Relationship between Anemia and Liver Disease
Keywords:
liver disease, anaemia, Severity of disease, Mortality rate, Quality – life surveyAbstract
Background: Chronic liver conditions are associated with several blood-related disorders. One of these is advanced liver disease, where iron deficiency anemia is often present.
Aim: This study aimed to assess outcomes related to anaemia’s effect on patients with liver disease.
Patients and methods: In the achievement of the study's objective, a total of 93 patients’ data were collected at different hospitals in Iraq in a period ranged between February 2023 - April 2024. All patients were diagnoses by measurement of HVPG, severity, and others in the laboratory. Our study evaluated mortality rate, Quality - of life, and development of liver disease in related with anemia.
Results: A total of 93 patients had anemia effect on liver disease. The findings shown females had 33.33% and males had of total patients. Fatigue was the most symptom prevalence in the patients, which include 26.88% of patients; the most common cuase was Bleeding, with 44 cases. Severity of anemia is classified into the patients with mild (Hb <12/<13.5 g/dL), include 62 cases; moderate (Hb < 10 g/dL), include 18; severe (Hb < 8 g/dL), include 13. Hepatic venous pressure gradient at patients with liver disease shown HVPG < 10 mm Hg with 19 cases, HVPG ≥ 10‐19 mm Hg with 47 cases, and HVPG ≥ 20 mm Hg with 27 cases.
Conclusion: Anemia is a factor that negatively affects patients with liver diseases, severely affecting their general health, quality of life, and performance of daily activities.
References
Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104 (8):2263‐2268.
Denny SD, Kuchibhatla MN, Cohen HJ. Impact of anemia on mortality, cognition, and function in community‐dwelling elderly. Am J Med. 2006;119 (4):327‐334.
Beghe C, Wilson A, Ershler WB. Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med. 2004;116 (Suppl 7A):3s‐10s.
Gaskell H, Derry S, Andrew Moore R, McQuay HJ. Prevalence of anaemia in older persons: a systematic review. BMC Geriatr. 2008; 8:1.
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352 (10):1011‐1023.
Terekeci HM, Kucukardali Y, Onem Y, et al. Relationship between anaemia and cognitive functions in elderly people. Eur J Intern Med. 2010;21 (2):87‐90.
Hong CH, Falvey C, Harris TB, et al. Anemia and risk of dementia in older adults: findings from the health ABC study. Neurology. 2013;81 (6):528‐533.
Jeong S‐M, Shin DW, Lee JE, Hyeon JH, Lee J, Kim S. Anemia is associated with the incidence of dementia: a national health screening study in Korea involving 37,900 persons. Alzheimers Res Ther. 2017; 9:94.
Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001;91 (12):2214‐2221.
Mandorfer M, Payer BA, Scheiner B, et al. Health‐related quality of life and severity of fatigue in HIV/HCV co‐infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin. Liver Int. 2014;34 (1):69‐77.
Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288 (12):1499‐1507.
Maruyama S, Hirayama C, Yamamoto S, et al. red blood cell status in alcoholic and non‐alcoholic liver disease. J Lab Clin Med. 2001;138 (5):332‐337.
Mathurin SA, Aguero AP, Dascani NA, et al. Anemia in hospitalized patients with cirrhosis: prevalence, clinical relevance, and predictive factors. Acta Gastroenterol Latinoam. 2009;39 (2):103‐111.
Qamar AA, Grace ND, Groszmann RJ, et al. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol. 2009;7 (6):689‐695.
Kalaitzakis E, Josefsson A, Castedal M, et al. Hepatic encephalopathy is related to anemia and fat‐free mass depletion in liver transplant candidates with cirrhosis. Scand J Gastroenterol. 2013;48 (5):577‐584. [PubMed] [Google Scholar]
Reiberger T, Puspok A, Schoder M, et al. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr. 2017;129 (Suppl 3):135‐158.
Ripoll C, Garcia‐Tsao G. The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis. 2011;43 (5):345‐351.
Luo J‐C, Leu H‐B, Hou M‐C, et al. Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population‐based cohort study. Aliment Pharmacol Ther. 2012;36 (6):542‐550.
Gado A, Ebeid B, Axon A. Prevalence and outcome of peptic ulcer bleeding in patients with liver cirrhosis. Alexandria J Med. 2014;50 (2):143‐148.
Alexopoulou A, Vasilieva L, Kanellopoulou T, Pouriki S, Soultati A, Dourakis SP. Presence of spur cells as a highly predictive factor of mortality in patients with cirrhosis. J Gastroenterol Hepatol. 2014;29 (4):830‐834.
Vassiliadis T, Mpoumponaris A, Vakalopoulou S, et al. Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: Incidence and correlation with disease severity and survival. Hepatol Res. 2010;40 (2):161‐170.
Lu YF, Li XQ, Han XY, Gong XG, Chang SW. Peripheral blood cell variations in cirrhotic portal hypertension patients with hypersplenism. Asian Pac J Trop Med. 2013;6 (8):663‐666.
Lv Y, Yee Lau W, Wu H, et al. Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly. Exp Biol Med (Maywood). 2017;242 (7):744‐749.
Lindenbaum J, Roman MJ. Nutritional anemia in alcoholism. Am J Clin Nutr. 1980;33 (12):2727‐2735.
Gkamprela E, Deutsch M, Pectasides D. Iron deficiency anemia in chronic liver disease: etiopathogenesis, diagnosis and treatment. Ann Gastroenterol. 2017;30 (4):405‐413.
Gonzalez‐Casas R, Garcia‐Buey L, Jones EA, Gisbert JP, Moreno‐Otero R. Systematic review: hepatitis‐associated aplastic anaemia–a syndrome associated with abnormal immunological function. Aliment Pharmacol Ther. 2009;30 (5):436‐443.
Kalaitzakis E, Josefsson A, Castedal M, et al. Factors related to fatigue in patients with cirrhosis before and after liver transplantation. Clin Gastroenterol Hepatol. 2012;10 (2):174‐181, 81.e1.
Les I, Doval E, Flavià M, et al. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastro Hepatol. 2010;22 (2):221‐227.
Gungor G, Akyildiz M, Keskin M, et al. Is there any potential or additive effect of anemia on hepatorenal syndrome? Turkish J Gastroenterol. 2016;27 (3):273‐278.
de Franchis R, Baveno V. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63 (3):743‐752.
McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004;20 (9):1501‐1510.
Ferlitsch A, Bota S, Paternostro R, et al. Evaluation of a new balloon occlusion catheter specifically designed for measurement of the hepatic venous pressure gradient. Liver Int. 2015;35 (9):2115‐2120.
Reiberger T, Ferlitsch A, Payer BA, et al. Non‐selective beta‐blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis. J Gastroenterol. 2012;47 (5):561‐568.
Reiberger T, Ferlitsch A, Payer BA, et al. Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single-center experience. Wien Klin Wochenschr. 2012;124 (11):395‐402.
Schwabl P, Bota S, Salzl P, et al. new reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension. Liver Int. 2015;35 (2):381‐390.
Margini C, Murgia G, Stirnimann G, et al. Prognostic significance of controlled attenuation parameter in patients with compensated advanced chronic liver disease. Hepatol Commun. 2018;2 (8):929‐940.
Abraldes JG, Bureau C, Stefanescu H, et al. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the "Anticipate" study. Hepatology. 2016;64 (6):2173‐2184.
Hernaez R, Sola E, Moreau R, Gines P. Acute‐on‐chronic liver failure: an update. Gut. 2017;66 (3):541‐553.
Scheiner B, Steininger L, Semmler G, et al. Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease. Liver Int. 2019;39 (1):127‐135.
